We’ve recently updated our valuation analysis.

Asana Valuation

Is ASAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASAN?

Other financial metrics that can be useful for relative valuation.

ASAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.4x
Enterprise Value/EBITDA-7.1x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ASAN's PS Ratio compare to its peers?

The above table shows the PS ratio for ASAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average10.7x
BRZE Braze
9.2x24.7%US$3.0b
ESMT EngageSmart
11.2x24.3%US$3.1b
NCNO nCino
7.7x18.8%US$2.9b
SPT Sprout Social
14.7x24.6%US$3.5b
ASAN Asana
5.9x20.1%US$3.0b

Price-To-Sales vs Peers: ASAN is good value based on its Price-To-Sales Ratio (5.9x) compared to the peer average (10.7x).


Price to Earnings Ratio vs Industry

How does ASAN's PE Ratio compare vs other companies in the US Software Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.6%
n/an/an/a

Price-To-Sales vs Industry: ASAN is expensive based on its Price-To-Sales Ratio (5.9x) compared to the US Software industry average (4.4x)


Price to Sales Ratio vs Fair Ratio

What is ASAN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASAN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.9x
Fair PS Ratio7x

Price-To-Sales vs Fair Ratio: ASAN is good value based on its Price-To-Sales Ratio (5.9x) compared to the estimated Fair Price-To-Sales Ratio (7x).


Share Price vs Fair Value

What is the Fair Price of ASAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ASAN ($14.22) is trading above our estimate of fair value ($9.25)

Significantly Below Fair Value: ASAN is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ASAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$14.22
US$18.77
+32.0%
28.4%US$30.00US$10.00n/a13
Jan ’24US$13.77
US$20.15
+46.4%
25.7%US$30.00US$12.00n/a13
Dec ’23US$18.08
US$25.64
+41.8%
28.0%US$43.00US$15.00n/a14
Nov ’23US$20.42
US$26.84
+31.4%
24.1%US$43.00US$15.00n/a14
Oct ’23US$22.23
US$28.13
+26.5%
24.9%US$43.00US$15.00n/a14
Sep ’23US$17.82
US$33.15
+86.0%
54.4%US$88.00US$13.00n/a13
Aug ’23US$19.51
US$33.33
+70.9%
56.2%US$88.00US$13.00n/a12
Jul ’23US$17.88
US$36.33
+103.2%
47.9%US$88.00US$21.00n/a12
Jun ’23US$21.20
US$48.17
+127.2%
41.5%US$88.00US$19.00n/a12
May ’23US$26.80
US$53.17
+98.4%
28.7%US$88.00US$32.00n/a12
Apr ’23US$40.00
US$55.69
+39.2%
30.5%US$88.00US$32.00n/a13
Mar ’23US$54.96
US$83.77
+52.4%
23.8%US$110.00US$57.00n/a13
Feb ’23US$53.41
US$87.31
+63.5%
19.9%US$110.00US$60.00n/a13
Jan ’23US$74.55
US$100.50
+34.8%
23.1%US$143.00US$66.00US$13.7712
Dec ’22US$89.96
US$111.00
+23.4%
23.4%US$151.00US$71.00US$18.0812
Nov ’22US$135.28
US$106.00
-21.6%
23.7%US$151.00US$71.00US$20.4212
Oct ’22US$101.87
US$85.83
-15.7%
22.7%US$115.00US$37.00US$22.2312
Sep ’22US$77.28
US$63.92
-17.3%
28.7%US$90.00US$34.00US$17.8212
Aug ’22US$71.06
US$57.08
-19.7%
27.6%US$80.00US$34.00US$19.5112
Jul ’22US$61.33
US$47.00
-23.4%
16.5%US$65.00US$34.00US$17.8811
Jun ’22US$37.00
US$38.36
+3.7%
11.2%US$45.00US$28.00US$21.2011
May ’22US$33.32
US$37.64
+13.0%
14.2%US$45.00US$27.00US$26.8011
Apr ’22US$30.81
US$37.40
+21.4%
14.8%US$45.00US$27.00US$40.0010
Mar ’22US$36.97
US$34.00
-8.0%
18.3%US$41.00US$20.00US$54.9610
Feb ’22US$35.46
US$34.00
-4.1%
18.3%US$41.00US$20.00US$53.4110
Jan ’22US$29.55
US$32.40
+9.6%
17.5%US$40.00US$20.00US$74.5510

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies